Valuation: Celltrion, Inc.

Capitalization 40,891B 27.41B 23.48B 21.47B 20.33B 37.65B 2,621B 37.95B 256B 99.54B 1,245B 103B 101B 4,335B P/E ratio 2026 *
31.2x
P/E ratio 2027 * 26x
Enterprise value 42.83B 28.71M 24.6M 22.49M 21.3M 39.43M 2.75B 39.75M 268M 104M 1.3B 108M 105M 4.54B EV / Sales 2026 *
8.04x
EV / Sales 2027 * 6.86x
Free-Float
58.45%
Yield 2026 *
0.4%
Yield 2027 * 0.43%
1 day+2.41%
1 week-3.65%
Current month-2.69%
1 month-2.01%
3 months-18.03%
6 months-0.51%
Current year+7.79%
1 week 187,400
Extreme 187400
197,800
1 month 187,400
Extreme 187400
212,000
Current year 187,400
Extreme 187400
251,000
1 year 144,615.38
Extreme 144615.3846
251,000
3 years 119,963.37
Extreme 119963.37
251,000
5 years 119,963.37
Extreme 119963.37
259,410.96
10 years 65,004.08
Extreme 65004.0844
341,497.26
Manager TitleAgeSince
Chief Executive Officer 42 26/03/2021
Chief Executive Officer 65 20/03/2015
President 50 13/02/2026
Director TitleAgeSince
Director/Board Member 75 -
Chairman 68 -
Director/Board Member 61 01/04/2005
Change 5d. change 1-year change 3-years change Capi.($)
+2.41%-3.65%+31.50%+27.88% 27.41B
-0.40%-2.22%-16.61%-19.18% 42.28B
-3.77%-3.91%+38.50%+27.79% 33.87B
-0.31%+4.88%+278.60%+477.77% 31.78B
-0.99%-4.46%+20.35%-9.30% 28.49B
+0.78%-0.26% - - 15.25B
-1.50%-14.49%+198.14%+4,123.83% 13.31B
-2.47%-0.45%+132.15%+113.12% 12.51B
-0.64%-0.54%+6.23%-2.45% 12.2B
-1.08%-2.23%+43.68%+100.61% 11.97B
Average -0.80%-2.70%+81.39%+537.79% 22.91B
Weighted average by Cap. -0.77%-2.41%+73.83%+342.72%

Financials

2026 *2027 *
Net sales 5,327B 3.57B 3.06B 2.8B 2.65B 4.9B 341B 4.94B 33.39B 12.97B 162B 13.4B 13.12B 565B 6,114B 4.1B 3.51B 3.21B 3.04B 5.63B 392B 5.67B 38.31B 14.88B 186B 15.38B 15.05B 648B
Net income 1,388B 930M 797M 729M 690M 1.28B 88.94B 1.29B 8.7B 3.38B 42.26B 3.49B 3.42B 147B 1,676B 1.12B 963M 880M 834M 1.54B 107B 1.56B 10.51B 4.08B 51.06B 4.22B 4.13B 178B
Net Debt 1,936B 1.3B 1.11B 1.02B 963M 1.78B 124B 1.8B 12.13B 4.71B 58.96B 4.87B 4.77B 205B 1,036B 695M 595M 544M 515M 954M 66.41B 962M 6.49B 2.52B 31.56B 2.61B 2.55B 110B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
14/05/26 195,100.00 +2.41% 701,802
13/05/26 190,500.00 -1.45% 785,326
12/05/26 193,300.00 +1.05% 1,168,312
11/05/26 191,300.00 -3.58% 864,117
08/05/26 198,400.00 -2.02% 620,707
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
195,100.00KRW
Average target price
262,833.33KRW
Spread / Average Target
+34.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock